Aktia Bank Oyj (0QF8)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 12.42 |
|---|---|
| 52-week range | 9.51 – 13.36 |
| Return, 1 month / 3 months | −4.6% / +9.3% |
| Return, 1 year / 3 years | +30.7% / +64.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 20.4% |
| Worst drawdown (1 year) | -10.5% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aktia Bank is a Finnish financial services group based in Helsinki. It provides banking services to private customers, small and medium-sized companies and institutional clients, and it offers wealth management and asset management services. Through its insurance arm it also provides life insurance and savings products. The group operates mainly in the Finnish market, with a branch network and digital services serving households and businesses across the country.
On this site Aktia Bank Oyj appears as a stock on the London Exchange (UK), code 0QF8, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aktia Bank Oyj (0QF8) trades on the London Exchange in UK. It last closed at EUR 12.42 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 679 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.7% and over the last three months it rose 9.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.7% | ||
| From 52-week high | -6.9% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.3% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 37.0% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.5% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −4.6% |
| 3 months | +9.3% |
| 6 months | +6.0% |
| 1 year | +30.7% |
| 3 years | +64.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.63 / 11.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | EUR 0.8000 |
| 4 Apr 2025 | EUR 0.8200 |
| 4 Apr 2024 | EUR 0.7000 |
| 6 Apr 2023 | EUR 0.4300 |
| 7 Apr 2022 | EUR 0.5600 |
| 6 Oct 2021 | EUR 0.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.